Trupanion (NASDAQ:TRUP) CEO Margaret Tooth Sells 1,000 Shares of Stock

Key Points

• CEO Margaret Tooth sold 1,000 Trupanion shares at an average price of $25.84, generating $25,840. The sale was made under a pre-arranged Rule 10b5-1 plan, leaving her with 184,952 shares.
• Trupanion shares recently traded at $26.57, with a market capitalization of approximately $1.17 billion. The stock has ranged from $21.16 to $46.98 over the past year.
• The company exceeded quarterly expectations, reporting $0.16 in earnings per share versus a $0.11 consensus estimate and revenue of $392.93 million, up 11.1% year over year. Analysts maintain a consensus “Hold” rating with an average price target of $38.40.

Trupanion, Inc. (NASDAQ:TRUP - Get Free Report) CEO Margaret Tooth sold 1,000 shares of the stock in a transaction that occurred on Friday, October 9th. The shares were sold at an average price of $25.84, for a total transaction of $25,840.00. Following the sale, the chief executive officer directly owned 184,952 shares of the company's stock, valued at approximately $4,779,159.68. This represents a 0.54% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Margaret Tooth also recently made the following trade(s):

• On Friday, September 11th, Margaret Tooth sold 1,000 shares of Trupanion stock. The stock was sold at an average price of $25.00, for a total transaction of $25,000.00.
• On Tuesday, August 25th, Margaret Tooth sold 491 shares of Trupanion stock. The stock was sold at an average price of $31.84, for a total transaction of $15,633.44.
• On Tuesday, August 11th, Margaret Tooth sold 978 shares of Trupanion stock. The shares were sold at an average price of $29.05, for a total value of $28,410.90.

Trupanion Price Performance

Shares of NASDAQ TRUP traded up $0.28 during trading on Tuesday, hitting $26.57. The company had a trading volume of 273,520 shares, compared to its average volume of 440,041. Trupanion, Inc. has a 52 week low of $21.16 and a 52 week high of $46.98. The business's 50-day moving average is $26.95 and its 200 day moving average is $25.51. The company has a market cap of $1.17 billion, a P/E ratio of 50.13, a PEG ratio of 1.80 and a beta of 1.44. The company has a debt-to-equity ratio of 0.24, a quick ratio of 1.77 and a current ratio of 1.77.

Trupanion (NASDAQ:TRUP - Get Free Report) last released its quarterly earnings data on Wednesday, August 5th. The financial services provider reported $0.16 earnings per share for the quarter, topping the consensus estimate of $0.11 by $0.05. The business had revenue of $392.93 million during the quarter, compared to analyst estimates of $389.72 million. Trupanion had a return on equity of 5.96% and a net margin of 1.53%. The company's revenue was up 11.1% compared to the same quarter last year. During the same period last year, the company posted $0.22 EPS. Equities research analysts predict that Trupanion, Inc. will post 0.63 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on the company. Weiss Ratings raised Trupanion from a "hold (c-)" rating to a "hold (c)" rating in a report on Tuesday, September 29th. Atlantic Securities set a $42.00 price target on Trupanion in a research note on Wednesday, July 15th. Zacks Research cut Trupanion from a "strong-buy" rating to a "hold" rating in a research note on Monday, August 24th. Piper Sandler downgraded Trupanion from an "overweight" rating to a "neutral" rating and cut their price objective for the stock from $45.00 to $32.00 in a report on Wednesday, August 26th. Finally, Stifel Nicolaus upped their price objective on shares of Trupanion from $28.00 to $29.00 and gave the company a "hold" rating in a research note on Thursday, August 20th. One equities research analyst has rated the stock with a Buy rating and five have given a Hold rating to the company's stock. According to MarketBeat, the stock presently has a consensus rating of "Hold" and an average price target of $38.40.

Hedge Funds Weigh In On Trupanion

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in TRUP. Bank of New York Mellon Corp acquired a new position in shares of Trupanion in the 2nd quarter valued at about $4,631,000. Bank of America Corp DE purchased a new stake in shares of Trupanion in the second quarter worth approximately $14,262,000. Renaissancere Holdings Ltd. purchased a new stake in shares of Trupanion in the second quarter worth approximately $6,514,510. GSA Capital Partners LLP acquired a new stake in shares of Trupanion during the second quarter worth approximately $1,394,000. Finally, Legal & General Group Plc acquired a new stake in shares of Trupanion during the second quarter worth approximately $1,938,000.

About Trupanion

Trupanion, Inc is a pet insurance company that provides medical insurance for cats and dogs. Its coverage is designed to help pet owners manage eligible veterinary expenses, including treatment for accidents, illnesses and other covered medical conditions.

The company offers subscription-based insurance plans primarily through direct-to-consumer channels and partnerships with veterinary practices. Trupanion also provides tools intended to streamline claims processing and enable participating veterinarians to receive payments directly, reducing the need for pet owners to pay eligible costs upfront and seek reimbursement.

Founded in 2000, Trupanion is headquartered in Seattle, Washington.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.